Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function

被引:53
作者
Barry, SC
Korpelainen, E
Sun, Q
Stomski, FC
Moretti, PAB
Wakao, H
DAndrea, RJ
Vadas, MA
Lopez, AF
Goodall, GJ
机构
[1] INST MED & VET SCI,HANSON CTR CANC RES,ADELAIDE,SA 5000,AUSTRALIA
[2] UNIV TOKYO,INST MOL & CELLULAR BIOSCI,TOKYO,JAPAN
关键词
D O I
10.1182/blood.V89.3.842
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor. and IL-5 receptor alpha chains are each composed of three extracellular domains. a transmembrane domain and a short intracellular region. Domains 2 and 3 constitute the cytokine receptor module (CRM), typical of the cytokine receptor superfamily; however. the function of the N-terminal domain is not known. We have investigated the functions of the N-terminal and C-terminal domains of the IL-3 receptor (IL-3R) alpha chain. We find that cells transfected with the receptor beta chain (h beta c) and a truncated IL-3R alpha that is devoid of the intracellular region fail to proliferate or to activate STAT5 in response to human IL-3, despite binding the IL-3 with affinity indistiguishable from that of full-length receptor. In addition, IL-3-induced phosphorylation of h beta c was not detected. Thus, the IL-3R alpha intracellular region does not contribute detectably to stabilization of the receptor/ligand complex, but is essential for signal propagation. In contrast, a truncated IL-3R alpha with the N-terminal domain deleted interacts functionally with the beta chain; mouse cells transfected with these receptor chains proliferate in response to human IL-3 and STAT5 transcription factor is activated. High- and low-affinity binding sites are retained, although the affinity for lL-3 is decreased 15-fold, indicating a significant role for the N-terminal domain in IL-3 binding. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:842 / 852
页数:11
相关论文
共 56 条
[1]   INTERLEUKIN-3 SIGNALS THROUGH MULTIPLE ISOFORMS OF STAT5 [J].
AZAM, M ;
ERDJUMENTBROMAGE, H ;
KREIDER, BL ;
XIA, M ;
QUELLE, F ;
BASU, R ;
SARIS, C ;
TEMPST, P ;
IHLE, JN ;
SCHINDLER, C .
EMBO JOURNAL, 1995, 14 (07) :1402-1411
[2]   CYTOKINE RECEPTOR GENES - STRUCTURE, CHROMOSOMAL LOCATION, AND INVOLVEMENT IN HUMAN-DISEASE [J].
BAIRD, PN ;
DANDREA, RJ ;
GOODALL, GJ .
LEUKEMIA & LYMPHOMA, 1995, 18 (5-6) :373-383
[3]  
BARRY SC, 1994, J BIOL CHEM, V269, P8488
[4]   HEMATOPOIETIC RECEPTORS AND HELICAL CYTOKINES [J].
BAZAN, JF .
IMMUNOLOGY TODAY, 1990, 11 (10) :350-354
[6]   HEMATOPOIETIN SUBFAMILY CLASSIFICATION BASED ON SIZE, GENE ORGANIZATION AND SEQUENCE HOMOLOGY [J].
BOULAY, JL ;
PAUL, WE .
CURRENT BIOLOGY, 1993, 3 (09) :573-581
[7]  
CONTRERAS M, 1996, METHOD ENZYMOL, V92, P277
[8]   CHARACTERIZATION OF CRITICAL RESIDUES IN THE CYTOPLASMIC DOMAIN OF THE HUMAN INTERLEUKIN-5 RECEPTOR-ALPHA CHAIN REQUIRED FOR GROWTH SIGNAL-TRANSDUCTION [J].
CORNELIS, S ;
FACHE, I ;
VANDERHEYDEN, J ;
GUISEZ, Y ;
TAVERNIER, J ;
DEVOS, R ;
FIERS, W ;
PLAETINCK, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (07) :1857-1864
[9]   DETAILED ANALYSIS OF THE IL-5-IL-5R-ALPHA INTERACTION - CHARACTERIZATION OF CRUCIAL RESIDUES ON THE LIGAND AND THE RECEPTOR [J].
CORNELIS, S ;
PLAETINCK, G ;
DEVOS, R ;
VANDERHEYDEN, J ;
TAVERNIER, J ;
SANDERSON, CJ ;
GUISEZ, Y ;
FIERS, W .
EMBO JOURNAL, 1995, 14 (14) :3395-3402
[10]   A NEW CYTOKINE RECEPTOR SUPERFAMILY [J].
COSMAN, D ;
LYMAN, SD ;
IDZERDA, RL ;
BECKMANN, MP ;
PARK, LS ;
GOODWIN, RG ;
MARCH, CJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (07) :265-270